Feasibility of a Molecular Characterisation Approach to Treatment — FOrMAT  

Advanced Gastrointestinal Cancers Clinical Trial

Official title: FOrMAT - Feasibility of a Molecular Characterisation Approach to Treatment

Status Recruiting

Clinical Trial Summary

This study will assess the feasibility of sequencing locally advanced/metastatic gastrointestinal cancers in real-time to enable future treatment stratification by molecular characteristics. Targeted next generation sequencing of a panel of genes will be performed on tumour specimens and results will be discussed at a Sequencing Tumour Board to establish if a patient is potentially suitable for a targeted therapy.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Advanced Gastrointestinal Cancers
• Gastrointestinal Neoplasms

• NCT number: NCT02112357
• Study type: Observational
• Source: Royal Marsden NHS Foundation Trust
• Contact: Dr. Naureen Starling, BSc, MBBS, MRCP
• Phone: +44 (0)208 661 3156
• Email: naureen.starling@rmh.nhs.uk
• Status: Recruiting
• Phase: N/A
• Start date: February 2014